Navigation Links
EU Study Shows Once-Daily Lisdexamfetamine Dimesylate (LDX) Effective for Symptom Control in Children and Adolescents with ADHD
Date:10/21/2011

states.- The HUI2 consists of seven attributes (sensation, mobility, emotion, cognition, selfcare, pain and fertility), with three to five levels, leading to 24,000 possible health states.[16]
  • WFIRS-P is a scale to be completed by the parent/guardian of a child and evaluates how an individual is able to function; questions are framed to assess how often an individual's behaviour or emotional problems have impacted various clinically-relevant domains of functioning.[17]

  • For further information please contact:


        
        Investor Relations
        Eric Rojas (erojas@shire.com), +1-781-482-0999
        Sarah Elton-Farr, +44-1256-894-157


        Media
        Jessica Mann (jmann@shire.com), +44-1256-894-280
        Matthew Cabrey (mcabrey@shire.com), +1-484-595-8248
        Nicole Barraud (nbarraud@shire.com)  + 41-22-419-4056
        Emma Overington (emma.overington@porternovelli.co.uk),
        +44-7720-277-120
        Kim Pickworth (kim.pickworth@porternovellinovelli.co.uk),
        +44-7720-277-175

    SHIRE PLC

    Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal diseases and regenerative medi
    '/>"/>

    SOURCE Shire plc
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
    3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
    5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
    6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
    7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
    8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
    9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
    10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
    11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2013)... NEW ORLEANS , May 22, 2013 /PRNewswire/ ... period for commercially-insured patients with Type 2 diabetes, ... shown to improve health outcomes and can lead ... studies presented at the International Society for Pharmacoeconomics ... The two studies, sponsored by Valeritas, ...
    (Date:5/22/2013)... 2013   Life Line Screening  (LLS), a ... the creation of a unique partnership with MCM ... MCM is a population health management organization. LLS will ... clients. These important expanded services will help MCM and ... prevention reduces cost of care when individuals are able ...
    (Date:5/22/2013)... May 22, 2013  Avanir Pharmaceuticals, Inc. (NASDAQ: ... overview of the company at the following conferences. ... Presentation date: Wednesday May 29, 2013 , Presentation time: ... Healthcare Conference , Presentation date: Wednesday June 5, 2013 ... A live webcast and 30-day archive of ...
    Breaking Medicine Technology:Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2
    ... MOUNTAIN VIEW, Calif. , Jan. 28 Omnicell, Inc. (Nasdaq: ... facilities, today announced results for its fourth quarter and year ended ... fourth quarter of 2009 was $54.7 million , up $0.7 ... $7.4 million or 11.9% from the fourth quarter of 2008. ...
    ... , SAN DIEGO , Jan. 28 ... Phase II clinical trial evaluating CTS-1027 in combination with pegylated ... activity, safety and tolerability of the triple combination will be ... is a significant unmet medical need in HCV patients who ...
    Cached Medicine Technology:Omnicell Announces Fourth Quarter and Full-Year 2009 Results 2Omnicell Announces Fourth Quarter and Full-Year 2009 Results 3Omnicell Announces Fourth Quarter and Full-Year 2009 Results 4Omnicell Announces Fourth Quarter and Full-Year 2009 Results 5Omnicell Announces Fourth Quarter and Full-Year 2009 Results 6Omnicell Announces Fourth Quarter and Full-Year 2009 Results 7Omnicell Announces Fourth Quarter and Full-Year 2009 Results 8Omnicell Announces Fourth Quarter and Full-Year 2009 Results 9Omnicell Announces Fourth Quarter and Full-Year 2009 Results 10Omnicell Announces Fourth Quarter and Full-Year 2009 Results 11Omnicell Announces Fourth Quarter and Full-Year 2009 Results 12Omnicell Announces Fourth Quarter and Full-Year 2009 Results 13Omnicell Announces Fourth Quarter and Full-Year 2009 Results 14Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV) 2Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV) 3
    (Date:5/22/2013)... People in the United States have been ... shortages. In much of the world, water shortages are normal ... Kleyne. She warns against taking water for granted and provides ... so easily in the United States. , Sharon Kleyne is ... show, heard live or by podcast on World Talk Radio, ...
    (Date:5/22/2013)... (PRWEB) May 22, 2013 Bodybuilding.com ... Memorial Day (May 27, 2013) Bodybuilding.com will be donating $1 ... the amount. , “We are extremely grateful for the ... Armed Forces,” said Ryan DeLuca, CEO and founder of Bodybuilding.com. ... who have sacrificed so much. Hire Heroes USA is an ...
    (Date:5/22/2013)... Twenty student-led startup companies at Arizona ... an intensive startup accelerator designed to help them execute ... create local jobs as part of ASU’s Edson ... initiative offers approximately 20 student teams up to $20,000 ... to launch their for-profit, more-than-profit or nonprofit ventures. The ...
    (Date:5/22/2013)... Researchers in genomic health disparities from the University of ... School of Medicine have teamed up to hold the ... Health Disparities in Genomic Medicine." The theme of ... business and government to reduce these disparities. , Despite ... States, individuals within underserved groups continue to be more ...
    (Date:5/22/2013)... Johns Hopkins researchers report that hospitals may be ... are complicated by preventable bloodstream infections contracted in ... new study, reported online in the American ... that an ICU patient who develops an avoidable ... times more to care for than a similar ...
    Breaking Medicine News(10 mins):Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 2Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 3Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 4Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 5Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 6Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 7Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 8Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 9Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4
    ... have said that sleep would probably help the human brain ... facts.// ,It was reported that previous studies had ... steps of learning to tap numeric sequences on a keyboard. ... declarative memory like those used for recalling the facts for ...
    ... (MIMS) is planning to launch a chain of satellite hospitals ... of non-resident Indian (NRI) doctors residing in Gulf Cooperation Council ... Kottakal in Malappuram district of the state for the purpose, ... ,MIMS chairman Azad Moopen told the newspaper that the ...
    ... Zealand Food Safety Authority (NZFSA) has warned people against ... bags are clearly labelled as requiring to be cooked ... is known to sometimes carry norovirus, which causes a ... Korean oysters are packed frozen in 1kg bags and ...
    ... at the Institute Of Cancer Research have discovered a new ... disease.// ,It is found that if a person ... diagnosed with breast cancer doubles. This would serve as a ... of cancer and thereby help treat and prevent the disease. ...
    ... differently in the same organs of males and females ... sheds light on why the same disease often strikes ... respond differently to the same drug. ,"We ... vary in their relationship to different diseases," explained Xia ...
    ... begin before the age of 14 years are not only ... from alcohol until they're 21//, but they also tend to ... with alcohol throughout their lives. ,The study's lead ... of Public Health's Youth Alcohol Prevention Centre said that while ...
    Cached Medicine News:Health News:Sleep Essential For A Strong Memory 2Health News:Same Genes Act Differently in Males and Females 2Health News:Same Genes Act Differently in Males and Females 3Health News:Alcoholism & Dependence Seen More Commonly In Early Alcohol Drinkers 2
    ... a range of Milli-Q ultrapure water ... quality requirements. Each of the five ... specifically target contaminants detrimental to particular ... and ICP-MS. The systems incorporate a ...
    ... developed a range of Milli-Q ultrapure ... water quality requirements. Each of the ... to specifically target contaminants detrimental to ... biology and ICP-MS. The systems incorporate ...
    ... a range of Milli-Q ultrapure water ... quality requirements. Each of the five ... specifically target contaminants detrimental to particular ... and ICP-MS. The systems incorporate a ...
    ... has developed a range of Milli-Q ... specific water quality requirements. Each of ... designed to specifically target contaminants detrimental ... molecular biology and ICP-MS. The systems ...
    Medicine Products: